2022 American Transplant Congress
Ex Vivo End Ischemic Hypothermic Oxygenated Perfusion (hope) Versus Static Cold Storage Prior To Liver Transplantation – Preliminary Results Of The Bridge To Hope Pivotal Multicenter Randomized Controlled Clinical Trial On The Safety And Effectiveness Of The Vitasmart Liver Machine Perfusion System (clinicaltrials.gov: Nct05045794)
*Purpose: Ex vivo end ischemic hypothermic oxygenated machine perfusion (HOPE) is a simple technique to improve liver transplant (LT) results and the donor shortage. HOPE…2022 American Transplant Congress
Tele-Health Implementation During Covid19 Pandemic in Liver Transplant Population: A Focus on Medication Adherence, Patient Satisfaction, Clinical Outcomes and Possible Cost Impact
*Purpose: The COVID-19 pandemic affected many aspects of health care, including the provision of care in ambulatory care clinics, necessitating the utilization of telehealth. For…2022 American Transplant Congress
The Centennial Liver Allograft – Liver Function for Over 100 Years in 2 Different Individuals the Centennial Liver Allograft – Liver Function for Over 100 Years in 2 Different Individuals the Centennial Liver Allograft – Liver Function for Over 100 Years in 2 Different Individuals
Medicine, SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: We investigated the occurrence of deceased-donor liver transplants (DDLT) that have achieved or came close to 100 years of function first in the donor…2022 American Transplant Congress
A New Chapter In An Evolving Pandemic: Successful Pediatric Liver Transplantation With Covid+ Donors
*Purpose: We report the first two pediatric liver transplants utilizing allografts from COVID+ donors, infected at time of organ procurement, demonstrating a pivotal step toward…2022 American Transplant Congress
Variation in Adult Living Donor Liver Transplantation in the United States: Identifying Opportunities for Increased Utilization
*Purpose: To assess barriers to living donor liver transplant (LDLT) access in light of convincing evidence of survival benefits for patients with end-stage liver disease.*Methods:…2022 American Transplant Congress
Center-Level Variability in DDLT Rate Before and After the Implementation of MMaT/250 Score
Johns Hopkins Medical Institutions, Baltimore, MD
*Purpose: In 02/2020, OPTN replaced DSA/regional boundaries with acuity circles and substituted exception scores for individual patients to median-MELD-at-transplant within 250 nautical miles of a…2022 American Transplant Congress
The Paradox of Lifestyle – Related Liver Disease: ASH and NASH
*Purpose: In the last decade, the burden of lifestyle-related chronic disease has been on the rise and is considered a growing serious public health concern.…2022 American Transplant Congress
Oxygen Saturation During Donor Warm Ischemia Time and Outcome of Donation After Circulatory Death (DCD) Liver Transplantation: A Review of 1207 Cases
Loyola Univ Chicago, Maywood, IL
*Purpose: Donation after circulatory death (DCD) liver transplantation (LT) is associated with increased risk of graft failure due to the donor warm ischemia time (DWIT)…2022 American Transplant Congress
Variation in Immunosuppressive Regimen in Children Receiving Liver Transplants: An Analysis of the UNOS Database
*Purpose: Optimizing immunosuppression (IS) was identified as a priority for pediatric liver transplant (LT) families and providers in the Starzl Network, a multi-center learning health…2022 American Transplant Congress
Use of Monoclonal Antibodies for Treatment of Solid Organ Transplant Recipients with COVID-19: A Single Center Experience
*Purpose: The risk of severe COVID-19 requiring hospitalization and death is higher in solid organ transplant recipients (SOTr). There remains limited data on the use…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 180
- Next Page »